HPQNYSETechnology

HP INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$28.46

-3.33%

Alpha Vantage · 11/6/2026

Industry: Computer HardwareCategory: Domestic Common StockCurrency: USDNews: 1 recent

Analyze HPQ free

One-year price history

Adjusted daily closes · 252 observations · as of Nov 6, 2026

Historical data, not a forecast

1 month

-12.3%

3 months

-3.6%

6 months

+28.2%

1 year

+14.2%

Year to date

+32.6%

52-week range

$17.53 – $35.48

Fundamental snapshot

Latest reported period: Jul 31, 2026

Sharadar reported data

Market cap

$25.67B

P/E

10.5

P/B

-279

P/S

0.4

Revenue

$59.16B

Net income

$2.45B

Diluted EPS

2.61

Gross margin

19.90%

Net margin

4.10%

Return on equity

-727.30%

Total debt

$9.16B

Cash

$4.17B

Free cash flow

$3.88B

Latest eight reported quarters

Reported quarterly values, newest first

Period	Revenue	Net income	Gross margin	Net margin	Free cash flow
Jul 31, 2026	$15.68B	$661M	18.80%	4.20%	$1.55B
Apr 30, 2026	$14.41B	$450M	20.90%	3.10%	$756M
Jan 31, 2026	$14.44B	$545M	19.60%	3.80%	$150M
Oct 31, 2025	$14.64B	$795M	20.20%	5.40%	$1.43B
Jul 31, 2025	$13.93B	$763M	20.50%	5.50%	$1.45B
Apr 30, 2025	$13.22B	$406M	20.70%	3.10%	-$145M
Jan 31, 2025	$13.5B	$565M	21.00%	4.20%	$72M
Oct 31, 2024	$14.06B	$906M	21.40%	6.40%	$1.47B

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent HPQ news

All market news

Global Banking & Finance Review·Nov 4, 202657 signal

Who is Emma Walmsley? Meet HP Inc's New CEO and Former GSK Chief

HP Inc. has named Emma Walmsley, former GSK CEO and Microsoft board member, as its permanent CEO, effective January 4, 2027. She will succeed interim CEO Bruce Broussard and is tasked with navigating the company through a significant memory-chip shortage impacting the PC market. Walmsley brings extensive experience from her 17-year career at L'Oreal and her tenure as the first woman CEO of GSK, where she oversaw major strategic transformations and navigated challenges.

Original source